Building Blocks

<p>Versatile small molecule scaffold</p>

<p>2-(bromomethyl)-6-chloropyridine is a ligand that binds to metal atoms. It forms a complex with the metal atom by coordinating with two or more bromine atoms and one or two hydrogens. 2-(Bromomethyl)-6-chloropyridine has been shown to interact with pyridine, x-ray diffraction studies, crystal x-ray diffraction, and ligands in crystal x-ray diffraction studies. The conformation of this compound can be deformed by substituting the methyl group on the chloro group for other moieties. These interactions have been shown using X-Ray diffraction studies and crystal x-ray diffraction studies.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>6-chloro-5-methoxy-1H-indole is an aromatic compound that can be synthesized by the amination of acetyl chloride. This reaction is followed by a borohydride reduction of the imine, and then an acetylation of the resulting alcohol. The synthesis method involves two steps: first, a borohydride reduction of the imine using sodium borohydride; and second, an acetylation with chloral. The final product is purified by distillation and elemental analysis to determine yields.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>6-Amino-1H-pyrazolo[3,4-b]pyridine is a cholesterol inhibitor that belongs to the pyridine derivative class. It has been shown to decrease the level of total cholesterol and low density lipoprotein (LDL) cholesterol in rats with atherosclerosis. This drug inhibits protein synthesis by binding to the active site of HMG-CoA reductase and preventing it from forming an enzyme-substrate complex with cholesteryl ester. 6-Amino-1H-pyrazolo[3,4-b]pyridine is an enantiomeric mixture of two stereoisomers, R and S. The R isomer has been shown to be more potent than the S isomer in inhibiting HMG CoA reductase activity.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>R(+)-Baclofen.Hydrochloride is a GABA analogue that stimulates the GABA-benzodiazepine receptor complex and produces antinociception. It has been shown to be effective against diabetic neuropathy in rats, with no observed side effects. R(+)-Baclofen.Hydrochloride is used for the treatment of trigeminal neuralgia, butyric acid induced hyperalgesia and chronic constriction injury in rats. The main mechanism of action of R(+)-Baclofen.Hydrochloride is its ability to activate the benzodiazepine receptor by binding to it, which leads to mitochondrial membrane potential depolarization and an increase in the release of gamma-aminobutyric acid (GABA) from neurons.</p>

<p>Versatile small molecule scaffold</p>